Research letterPrevalence of moderate to severe acne in transgender adults: A cross-sectional survey
References (5)
- et al.
Dermatologic care for lesbian, gay, bisexual, and transgender persons: epidemiology, screening, and disease prevention
J Am Acad Dermatol
(2019) - et al.
Short- and long-term clinical skin effects of testosterone treatment in trans men
J Sex Med
(2014)
Cited by (10)
Acne treatment challenges – Recommendations of Latin American expert consensus
2024, Anais Brasileiros de DermatologiaPsychopharmacological Considerations for Gender-Affirming Hormone Therapy
2023, Harvard Review of PsychiatryCharacterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study
2023, Transgender HealthApproach the treatment of acne in transgender patients with sensitivity and awareness
2022, Drugs and Therapy PerspectivesTreating Acne in Transgender Persons Receiving Testosterone: A Practical Guide
2022, American Journal of Clinical Dermatology
Funding sources: Supported in part by Patient-Centered Outcomes Research Institute (PCORI) contract AD-12-11-4532 and grant R21HD076387 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (to Dr Goodman), the National Center for Advancing Translational Sciences grants UL1TR002378 and KL2TR002381 (to Dr Yeung), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases loan repayment program L30AR076081 (to Dr Yeung).
Disclosure: Dr. Yeung previously received an honorarium from Syneos Health. Ms Ragmanauskaite; Ms Zhang; Ms Kim; and Drs Tangpricha, Getahun, Silverberg, and Goodman have no conflicts of interest to declare.
Abstract presented at the American Acne and Rosacea Society and the Society of Investigative Dermatology meeting in Chicago, IL on May 8, 2019.
IRB approval status: Reviewed and approved by the Emory University IRB (no. 00113741).
Reprints not available from the authors.